Expedia Group reports Q2 results tonight with one of the cleanest pre-earnings setups it has seen all year — shorts are covering hard, the stock is at multi-month highs, and analysts have been lifting targets almost universally ahead of the print.
The short-covering story is the standout this week. Short interest has fallen nearly 15% over the past month to 5.9% of the free float — from around 9.6 million shares on July 23 down to 6.9 million by Tuesday. The pace of that unwind accelerated into the final sessions before tonight's release, with shorts shedding roughly 9% of their position in the past week alone. Borrowing costs have eased alongside the retreat, dropping 27% over the month to a negligible 0.37%. Availability is loose at 659%, meaning there is no meaningful squeeze dynamic at work here — this looks like voluntary covering rather than forced exits.
Options tell a slightly different story. The put/call ratio at 1.18 is actually running a touch below its 20-day average of 1.22, which is modestly unusual for EXPE — the ratio has persistently sat in a put-heavy range all summer, a reflection of structurally cautious positioning that has barely budged even as the stock has rallied. The z-score of -0.82 confirms the ratio is slightly less defensive than normal right now, consistent with shorts stepping back but options traders not yet making an aggressive bullish call. The 52-week range on PCR spans 0.86 to 1.39, so current levels are mid-range at best — not a ringing endorsement of the rally.
The Street has been moving firmly in one direction. Multiple analysts lifted targets in the past two weeks ahead of the print: Truist raised its target to $309 from $246 on Monday while keeping a Hold; UBS moved to $322 from $262 last Thursday; and Morgan Stanley nudged to $300 from $290. The bull targets cluster in the $310–$334 range, with Wedbush's recent Outperform initiation anchored at $334. That puts the consensus mean price target at roughly $294 — now slightly below the current stock price of $312, which reflects just how strongly EXPE has run into results. The stock is up 5.5% on the week and 16% over the past month. Bears on the Street point to VRBO's high average daily rates, EXPE's US-heavy mix relative to Booking Holdings, and rising pressure from direct-booking channels eating into OTA margins. Bulls counter with consistent profitability, a recovering corporate travel tailwind, and the ongoing technology investment cycle. The EV/EBITDA multiple is running at around 8.8x — down modestly over 30 days even as the stock has risen, suggesting earnings estimates have moved up with the price. The analyst recommendation divergence factor scores in the 98th percentile, meaning the spread between bull and bear views is extremely wide relative to history, a setup that tends to make the earnings reaction binary.
Peer divergence is worth noting into the print. BKNG fell 2.5% on the week and ABNB lost 2.1%, while EXPE added 5.5% — a pronounced outperformance that narrows if tonight's numbers disappoint. MMYT surged 17.7% on the week, suggesting demand signals from emerging-market travel were strong, which could be a read-through for Expedia's international exposure.
Past earnings reactions have not been kind in the near term. The May print produced a 6.8% one-day drop and a near-12% five-day decline. A June event registered only a 1% one-day fall but recovered 7.6% over five sessions. The pattern is uneven rather than reliably directional, which makes the 98th-percentile analyst divergence score all the more relevant — the stock tends to move, and the disagreement about where it goes next is near-historic.
Tonight's release is therefore less about whether travel demand is healthy and more about whether Expedia can demonstrate VRBO margin resilience, international growth progress, and any update on the technology-driven cost efficiency story that bulls are pricing into a stock now trading above the average Street target.
See the live data behind this article on ORTEX.
Open EXPE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
